# Patent

## Title
Smoker's requisite

## Abstract

A smoker's requisite embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof. The substance is embodied in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.

## Background
This application is a 371 of PCT/IB02/01112, filed Apr. 9, 2002 and claims the benefit of South African Application Nos. 2001/2893, filed Apr. 9, 2001, and 2001/4060, filed May 18, 2001.
This INVENTION relates to a smoker's requisite.
For the purposes of this specification, a “smoker's requisite” should be understood to mean an object or device such as a cigarette or pipe which is lit and smoked by a smoker and accordingly includes, without being limited thereto, plain and filter cigarettes, pipes, cigars, cheroots and the like and the term further includes within the scope of its meaning a “smoking accessory” by which is meant an object or device which is used together with a cigarette, pipe, cigar, cheroot or the like such as a filter, cigarette holder, cigar holder or the like.
According to a first aspect of the invention there is provided a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, the substance being embodied in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The substance or composition may be embodied in a component from which a smoker's requisite is made.
For example, it may be mixed with or impregnated into the tobacco of the smoker's requisite such as a cigarette or cigar prior to the manufacture of the requisite. It may be mixed with or impregnated into pipe tobacco or chewing tobacco. The substance may be crystallized or ground into a powder, dissolved or liquified prior to being mixed with or impregnated into the tobacco. A portion of a plant or a substance of the invention may be desiccated, ground, shredded or reduced to smaller particles and these particles may be incorporated into the requisite. Instead, the substance or composition may be impregnated into the paper of a cigarette or into a filter of a cigarette, cigar, pipe or the like.
The tobacco, filter or cigarette paper may be impregnated with the substance or composition by methods such as applying the substance in liquid form to the tobacco, filter or cigarette paper, by immersing the tobacco, filter, or cigarette paper in a solution of the substance, impregnating by pressure, chemically impregnating, using an adhesive, saturation, gaseous infusion, immersion, spraying, radiation, osmosis, friction, mixing, blending, infusion, coating or waxing. The substance or composition may be carried or cased in animal or plant fats or modifications of them such as tallow, palm butter, cocoa butter, synthetic fats, saccharides such as lactose, glucose or mannose or in polymers or polymeric substances such as gelatine, cellulose, polyethyleneglycol and polyvinyl alcohol. Alternatively it may be placed in or combined with calcium salts, waxes, paper, hemp, sisal, twine, water soluble materials. It may be in a membrane, sponge, sponge type matrix, porous or pumice type structure which may be rigid or flexible, porous or impervious.
In another embodiment of the invention, the particles are impregnated into the paper of the requisite by chemical impregnation using a dry or liquid chemical impregnation either during the manufacturing of the paper or during the manufacture of the requisite. For example, the substances or particles may be incorporated by mixing or blending the particles into a liquid or dry mix, which is then mixed into the pulp from which the paper or the constituents including the filter of the requisite are manufactured. Impregnation may be by soaking the paper or filter in a liquid containing the substances or extracts of the substances. Impregnation may be achieved through bonding the required substance or portions of the substance or ground or desiccated particles of the substance to the paper or filter of the requisite. This method includes bonding by pressure or the use of adhesives or bonding agents. Impregnation can also be achieved by spraying.
In other embodiments, similar methods are used to apply the substance or composition to cigar leaves.
The substance may be rolled into a filter, or form part of the filter paper or be impregnated into the filter paper. In an embodiment of the invention, the substance itself forms a filter or a part of a filter. For example, where the substance is a natural product which occurs in a plant, the filter may be constructed entirely or in part using material from the plant such as its leaf. The leaf may be used in its whole form or shredded and then shaped into a cigarette filter. The construction of the filter may then be similar to that of a conventional cigarette filter. In an embodiment of the invention the filter may be constructed entirely from the plant material or the plant material may be encased in an outer paper sheath in conventional fashion. For example, tea leaves such as green tea leaves may be rolled into a filter or may be used to make a filter.
In an embodiment of the invention, the substance or composition is sandwiched between the filter of a cigarette and the tobacco of the cigarette.
In another embodiment of the invention a carrier which carries the pharmaceutical products, food supplements, natural products or combinations thereof is incorporated or embodied in the smoker's requisite or smoking accessory. The carrier may be in the form of a cartridge, pill, package, membrane or screen which carries the substance and it may be located at any suitable position in the requisite or accessory.
For example, the cartridge or membrane may be located before, after, or in the filter. It may be placed in a smoker's requisite such as a cigarette at either end or at any point along the body of the requisite. The carrier may be refillable or rechargeable for multiple use or disposable.
The act of smoking will then cause at least some of the substance or composition to be carried with the smoke into the mouth, throat and/or lungs of the smoker and thereby cause the substance or composition to be ingested by the smoker.
The invention accordingly extends to a smoker's requisite or accessory which includes a component selected from one or more of tobacco, paper, a filter and a carrier, with a substance as described below embodied in the tobacco, paper, filter or cartridge.
It extends further to a smoker's requisite which includes a filter and in which the filter is formed from a substance as hereinbefore described.
The substance or composition may be selected from flavanols, anelgesics, anti-pyretics, anti-carcinogenic and chemo preventive agents, anti-oxidants, anxiolytics, angiogenisis inhibitors, anti-aging substances, antibiotics, antihistimines and anti-allergenics, anti-hypertensive agents, anti-inflammatories, memory and brain function treatment agents, cardiovascular and circulatory agents, diabetes treatments, anti-hypercholesterolaemics, immune system enhancers, immunizing agents, minerals, respiratory agents, sedatives, anti-stress agents, aphrodisiacs, sexual disfunction agents, enhancement drugs, tonics, stimulants and vitamins, anti-metabolites, nitrosoureas, tryptamine derivatives, proteins, steroids, vitamins and provitamins, statins, sulphonamides, substituted indoles, substituted imidazoles, metal-containing compounds, drug substances, anti-depressants, immunosuppressants, hormones, antibiotics, phytochemicals, and mixtures of any two or more thereof. Where the substance or composition comprises a mixture e.g. a mixture of natural products, such as a mixture of polyphenols, the substance or composition may comprise a portion or a combination of portions of such mixtures or a combination of such portion or portions with any of the other substances or compositions.
Where a natural substance such as a herb, plant or the like is used, the word “substance” refers to the natural or unrefined substance itself or to a partially or fully refined product produced, distilled, extracted or reduced from the substance.
The alkylating agent may be selected from alkyl sulphonates, ethyleneimine compounds and other alkylating agents. The N-mustard may, for example, be selected from chlorambucil, cyclophosphamide, melphalan, mustine and pipobroman. The alkyl sulphonate may be selected from busulphan and treosulfan. The ethyleneimine compound may be thiotepa. The alkylating agent may instead be selected from hexamethylmelamine, mitobronitol, mutolacetol and ethoglucid.
The substance may be selected from catechin, gallic acid, epigallocatechin gallate, epigallocatechin, epicatechin, epicatechin-3-gallate, epicatechin gallate, epigallocatechin-3-gallate. The tryptamine derivative may be selected from serotonin and melatonin. The protein may be selected from endostatin and angiostatin. The steroid may be selected from steroidal anti-inflammatories. It may for example be an estrogen or estrogen metabolite such as 2-methoxyestradiol.
The substance may be selected from tocopherol, alpha-tocopherol, beta-carotene, retinoic acid and ascorbic acid. The statins and compactins may be selected from lovastatin, simvastatin and pravastatin. The sulphonamide may be nimesulide. The substituted indole may be Lodine (etodolac). The metal-containing compound may be a selenium compound.
The natural product may be selected from lycopene, caffeine, prenyl flavonoids, Camelia sinensis and rosemary. The natural product may be of the type found in food and beverages such as the vegetables alfalfa, onions, spinach, broccoli, kale, garlic, red bell peppers and beets, fruits including bananas, red and white grapes, oranges, strawberries, kiwi fruit, grapefruit, pink grapefruit and their seeds, tomato and apple and beverages including teas from Camelia sinensis, apple juice, grape juice, red wine, tomato and orange, and cocoa. It may be plant substance such as Echinacea, ambrosia marijuana/cannabis/hemp or alfalfa. It may be plant material, for example plant material in its natural state from a plant having anti-carcinogenic or other medicinal properties.
The pharmaceutical product may be selected from anti-carcinogenic substances such as traodone, interferon, thalidomide, Col-3, tamoxifen, COX-2 inhibitors, celebrex, rofecoxib (vioxx), imatinib mesylate gleevec (STI 571), cyproheptadine, aspirin and paracetamol. Cyproheptadine is used as an adjunct to radiotherapy and the use of cyproheptadine may be advantageous in radiotherapy. Dosages of 200-300 mg or more of the targeted approach drugs such as C225 which is normally administered intravenously and the molecularly targeted drug such as gleevec result in blood counts in leukemia sufferers returning to normal with minimum side effects.
The anti-depressant may be selected from monoamine oxidase inhibitors such as the hydrazine derivatives, isocarboxazid, phenelzine, nialamide, iproniazid and mebanzine as well as the non-hydrazine monoamine oxidase inhibitors such as pargyline, the tricyclic anti-depressants such as dibenzazepine or zocyclohepetene derivatives such as amitriptyline, butriptyline, desipramine, clomipramine, protriptyline, nortriptyline, opipramol as well as trimipramine and iprindole which have different cyclic structures, and the tetracyclics maprotiline and mianserin.
The flavonoid may be a prenyl flavonoid of the type found in hops and beer i.e. chalcones from hops as well as prenylchalcones and prenylflavonones from naringeninand 2-hydroxy-2-methylbut-3-ene or linalool and xanthohumol from the prenylchalcone in beer.
The food supplement may be a mineral supplement such as a calcium supplement, a vitamin, tonic or stimulant.
The substance or composition may, instead, be a peroxide such as hydrogen peroxide or a synthetic anti-oxidant. The substance or composition may be a natural anti-carcinogen
catsclaw, olive leaf (as well as the extract of olive leaf and olive leaf concentrate), pau-d'arco, mistletoe (also sold as iscar and iscador) or cartilage including shark cartilage.
The substance may be selected from the substances and formulations set out in Tables 1 and 2. The amounts of the substance or substances embodied in a smoker's requisite or smoking accessory may be between the lower value as set out in column A of Table 1 and the higher value as set in column C of Table 1 or the amount set out in column C of Table 2. More particularly, the amounts may be as set out in column A of Table 1. Preferred amounts are set out in column B of Table 1 or column D of Table 2. Column C also represents the maximum and minimum daily dose of the relevant substance.
The invention extends to a carrier which is shaped and dimensioned to be received in a smoker's requisite or accessory selected from cigarettes, cigars, cigarette holders, cigar holders and removable filters which incorporates a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, the substance being incorporated in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The carrier may be a package, cartridge, pill, sponge, matrix, filter, porous membrane, tablet or string and may have any suitable shape. It may for example be cylindrical, round, rectangular, square, spherical, tubular or coin shaped. It may be manufactured as a polymeric tube and may be porous, impervious flexible or rigid. It may be a porous or perforated tube which may extend axially down the centre of a cigarette.
The substance may be incorporated into the requisite by manufacturing and configuring it in the form of a string and may be placed or inserted into the requisite or placed on the outside of the requisite. The substance may be impregnated into the string by various methods including use of adhesives, bonding agents, or by soaking, gaseous infusion, immersion, spraying, friction, glueing, impregnation by pressure, sealing, coating or waxing. The string, containing the required substance or plant, may contain binding materials or inert materials to hold or bind the substances together in the form of a string. If the substance to be incorporated is in dry powder, crystalline or granular form the string may be coated with a coating such as wax or fat such as bees wax or cocoa butter to bond the substance or powder. Alternatively, the string may be manufactured partially or wholly from or with the substance to be incorporated into the smoker's requisite.
The carrier provides insulation of the substance and protects it from oxidation, or destruction and to regulate the heat so as to regulate and control release of the substance (i.e. quantity and timing). This string may be stored or coiled into rolls from which lengths as required may be placed into the smoker's requisite at the time of manufacture of the smoker's requisite. Instead, the substance may be impregnated into or embodied in a prior made string. The substance may, instead, be embodied in a band of paper or similar material.
The bands may be applied onto or wrapped around the requisite or may be formed in the paper as an integral part of the paper from which the cigarette is manufactured. The required substance is then carried by the paper and forms an integral part of the cigarette paper. The incorporation or manufacture of the various bands may be done at the time of manufacture of the cigarette paper. These bands may be applied in ring form around the diameter of the smoker's requisite e.g. a cigarette or cigar in lengths which may be straight or otherwise along the length of the cigarette. These bands may also be applied to the cigarette in various patterns including coiled, spiral, in wave form along the length of the cigarette, in zigzag pattern and various other patterns.
The invention extends further to a smoking accessory selected from cigarette holders, cigar holders and detachable filters which incorporates a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof.
It extends further to a method of making a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, which includes combining a component of a smoker's requisite with the substance and using the component to make the requisite.
The invention extends, further, to a method of administering to a person a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof which includes the step of incorporating the substance in a smoker's requisite as hereinbefore described so that, when the smoker's requisite is smoked by a person, an amount of the substance or composition is ingested by the person during smoking.
The invention extends further to a method of administering to a person a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof which includes the step of incorporating the substance in a smoking accessory as hereinbefore described so that, when the smoking accessory is used together with a smoker's requisite, an amount of the substance is ingested by the person during smoking.
According to another aspect of the invention, there is provided a method of making a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, which includes incorporating a carrier which carries the substance in the smoker's requisite so that when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The substance may be a combination of one or more of the pharmaceutical products, food supplements and natural products.
In preferred embodiments of the invention the substance or composition comprises, in combination, novastatin and Lodine or in combination a statin such as mevacor (lovastatin) and a COX-2 inhibitor such as celebrex, vioxx or nimesulide or in combination mevacor (lovastatin) and Lodine XL. In another preferred embodiment of the invention the substance or composition comprises mycopene, a selenium compound and green tea. In another preferred embodiment the substance or composition comprises epigallocatechin-3-gallate, epigallocatechin, epicatechin gallate and/or epicatechin-3-gallate. In another preferred embodiment the substance or composition is a combination of epigallocatechin gallate and curcumin. A combination of catechins is better than epigallocatechin gallate alone for producing cell apoptosis. The effect is synergistically increased when catechins are combined with other anti-carcinogenic substances such as tamoxifen. In another preferred embodiment a seratonin antagonist such as periactin (cyproheptadine) can be used alone or in conjunction with melatonin. A dosage of 36 mg of melatonin daily as an adjuvant in conjunction with traditional cancer treatments reduces the side effects of toxic therapies and increases their effectiveness.
An anti-carcinogenic substance, for the purposes of this specification, is a substance which acts against cancer in a prophylactic fashion or is a substance which can be used in the treatment of cancer, for example in a chemotherapeutic fashion.
The smoking of a smoker's requisite or the use of a smoking accessory as hereinbefore described incorporating extracts of Camelia sinensis results in the ingestion of epigallocatechin gallate. This compound has been shown to be active amongst others against colon cancer, melanoma, breast cancer and lung cancer.
In order to inhale and ingest the various compounds and substances of the invention, certain of these have to be broken down, diffused or vapourised so that they can be transported into the draught or flow of air and smoke being drawn in by the smoker or diffused and released into the atmosphere where it could be breathed by a passive smoker.
Heat generated by the glowing end of a cigarette, will gradually permeate along the length of the cigarette. The resulting increase in temperature, depending upon the substance or composition used, will allow or cause the substance or composition to be progressively released and inhaled by the smoker. Different substances will be released at different temperatures. The end of a cigarette which is closest to the user when being smoked will initially be cooler than the opposite end and will gradually increase in temperature as the cigarette is smoked. The release of the substances is optimised by the positioning of the substances in the requisite. With certain substances that are more sensitive to heat or require only a small amount of heat to release them or their required active ingredient, the substance is placed at the end of the requisite closest to the smoker's mouth. At this end, the substance is not immediately subjected to the extreme heat generated at the lit end. This preserves the integrity of the substance for a longer period. The substance is then subjected to a gradual increase in temperature as the lit end approaches the area where the substance has been placed. The rise in temperature and/or the air drawn through the cigarette causes the active ingredients to be released. The constituents so released are then be ingested by the person smoking the requisite.
The substance or composition may be placed along the length of the cigarette or at any point where it will reach the optimal temperature for the optimal period of time. This would be predetermined before manufacture by taking into account which substance is to be used and may be determined by routine experimentation.
The cigarette or cigar holder may be openable by a flip, screw, bayonet taper or push-in mechanism and an anti-carcinogenic package, food supplement package, medication package or anti-depressant package, filter or membrane may be receivable in the accessory. The holder may be attachable to a cigarette or cigar by a push, taper or friction fit.
The invention extends to an anti-carcinogenic cartridge which can be inserted into a cigarette holder, cigar holder or pipe.
For purposes of this specification the words “substance”and “material” include any compound, mixture, blend, medication, formula, drug (synthetic or natural), hormone, plant, seed, pollen, flower, vegetable, fruit or bio-organism and includes the above in their natural, organic or synthetic form or a derivative or modification of any of them and when used in their whole, part, refined or unrefined form or only a portion or any constituent of, extract, fraction, molecule or distillate derived from any of the above or a portion of the aforegoing (extract) in its refined or unrefined form or a synthetically manufactured derivative or substitute of any of the aforegoing. Any of these may be used individually or in combination with each other or with other remedies, formulae or substances.
The mass and bulk of some of the formulae of this invention require that the formulation be carried in a cartridge which is inserted into a filter which is detachable from the cigarette. The detachable filter may be pre-packed with a substance of medication and may be in the form of a disposable single use filter or it may be used until the medication or substance is depleted. Alternatively the filter may be in a form where it may be re-used in which instance a fresh cartridge/carrier is inserted.
The filter is pushed onto the end of the requisite which may be filterless or already have a filter and may be held in place by a ringed sleeve which can be rigid or flexible.
The medication may then be incorporated into the filter by one of the methods described above or by the insertion of the “carrier”.
The medication can also be incorporated by the insertion of a porous membrane which carries the medication.
A non-porous membrane may be used behind which the medication is packed or stored. The medication may be sandwiched between two membranes or between a membrane and the tobacco portion of the requisite. Alternatively the medication may be carried or housed in a cartridge through which the smoke from the burning tobacco can pass. The cartridge may have a porous or non-porous membrane on one or both sides through which the smoke can pass.
The cartridge or carrier may be made from porous paper, material, or cellulose. When the detachable filter is forced onto the end of the requisite the membrane is pierced and the medication is exposed to the draught/flow of air which passes from the lit end of the requisite to the smokers mouth. The non-porous membrane may also be impregnated with a medication.
The cartridge or insert which is incorporated in the smoker's requisite or accessory protects the integrity of the active ingredients incorporated into the requisite or accessory both during the time the requisite is in storage and during the time it is being consumed and can reduce the temperature to which the substance is exposed during the smoking of the requisite and further allow for the pre-positioning of the substance within the requisite so that the timing of the release and the amount of the substance may be predetermined and controlled. The use of a cartridge or insert to incorporate any particular substance in a smoker's requisite allows easier incorporation of the substance during the manufacturing process. The use of a cartridge or insert allows easier substitution of alternate substances or medications to be incorporated into a requisite without major changes to the manufacturing process when a change of the substance is required.
To regulate the amount of active ingredient or substance released during the smoking of the requisite, the cartridge or insert may be rigid or flexible and may be porous. The degree of porosity may also be varied to determine the amount of air or smoke which passes through it. The draught of air or smoke passing through the insert or cartridge assisted by the heat, releases the active ingredient of the substance in the cartridge.
In addition to air or smoke passing through a selected substance or cartridge or insert, the active ingredients may be dispensed or released by air, smoke or heat passing over or around the substance, the cartridge or insert.
Alternatively the active ingredients can be released or diffused at the time that the cartridge or insert heats up or is burnt. When using this method the cartridge or insert may be of a non-porous or semi-porous nature.
More than one cartridge may be incorporated into a smoker's requisite. The content, make up and construction of the various cartridges may differ from each other and more than one type of cartridge or insert may be incorporated into a smoker's requisite.
The insert or cartridge carries the substance and dispenses or infuses the substance into the requisite either before or during the igniting and combustion of the smoker's requisite. Such infusion or dispensing into the requisite can be achieved by way of diffusion. The cartridge or insert may also be manufactured from a porous material or a porous membrane so that the substance can diffuse through the walls of the cartridge or insert. Alternatively dispensing or diffusion can be achieved by holes or perforations in the cartridge or insert.
The dosage or amount of substance delivered to the smoker can be varied by increasing or decreasing the quantity and size of cartridges incorporated into the requisite or increasing or decreasing the amount of string incorporated into the requisite or by varying the porosity of the insert or cartridge or by increasing the number or size or perforations in the insert or cartridge.
Instead the substance may be placed at any point in the requisite. The substance may be housed in a cavity or pocket anywhere in the requisite or in a cavity or pocket sandwiched between the filter and the section of the requisite containing the tobacco or within a cavity or pocket either in the tobacco portion or filter portion of the requisite or combined in the paper or glue.
In another embodiment of the invention, the substance in a desiccated, shredded or ground state may be blended into an inert carrier, which is then placed into the requisite or filter. The inert carrier, which encases the substance is selected so as to release the substance or the active material from the substance at a predetermined temperature and to protect the integrity of the substance from excessive heat until it can be ingested or inhaled by the smoker.
Another method of incorporation is to fold or roll the particles into the filter at the time of manufacture of the filter.
Another method of incorporation is to blend or mix the particles into the tobacco mix.
In yet another embodiment, the substance is incorporated into the filter of the requisite. The substance may be incorporated by rolling, folding or impregnating it into the filter or filter paper.
In yet another embodiment the Camellia sinensis or rosemary plant or certain of the constituents of the Camellia sinensis or rosemary plant or a combination of the plants may be incorporated into the body of the requisite where the tobacco is housed or used as described above.
In yet another embodiment, the process and method used in the manufacture of a conventional cigarette filter is employed using material selected from a plant.
In yet another embodiment the plant material may be incorporated into a filter made from the materials and according to the process employed in the manufacture of a conventional cigarette filter.
In yet another embodiment portions of the plant material are placed in a porous cartridge which is then incorporated into the smoker's requisite.
Naturally, more than one of the substances can be used in a single smoker's requisite or accessory.
The invention is now described, by way of example, with reference to the following Examples.


EXAMPLE 1
Mevacor (lovastatin) and Lodine XL were combined with cigarette tobacco and formed into a cigarette. The amount of Mevacor (lovastatin) incorporated was 50 mg and the amount of Lodine XL was 4 mg. The preferred daily dosage of lovastatin is 1000 mg and that of Lodine XL 80 mg per day.
EXAMPLE 2
Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of cyproheptadine incorporated was 0,2 mg. The preferred daily dosage of Cyproheptadine is 4 mg. The daily intake of Cyproheptadine may vary between 4-12 mg.
EXAMPLE 3
Melatonin was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of melatonin incorporated was 1,8 mg. The preferred daily dosage of melatonin is 36 mg. The daily intake of melatonin may vary between 3-200 mg.
EXAMPLE 4
Tamoxifen was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of tamoxifen incorporated was 1 mg. The preferred daily dosage of tamoxifen is 20 mg. The daily intake of tamoxifen may vary between 10-40 mg.
EXAMPLE 5
A formulation consisting of 1,8 mg of Melatonin and 0,2 mg Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette.
EXAMPLE 6
Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of cyproheptadine was selected so that, by smoking a predetermined number of cigarettes per day, a dose of 4 mg of the cyproheptadine was delivered to a smoker.
EXAMPLE 7
Flavonols were mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of flavanols incorporated was 25 mg. The preferred daily dosage of flavanols is 20 mg. The daily intake of flavonols may vary between 10-1000 mg.
EXAMPLE 8
Endostatin was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of endostatin incorporated was 15 mg. The preferred daily dosage of endostatin is 300 mg. The daily intake of indostatin may vary between 3,75-600 mg.
EXAMPLE 9
Melatonin and Cyproheptadine were combined with cigarette tobacco and formed into a cigarette. The amount of Melatonin incorporated was 1,8 mg and the amount of Cyproheptadine was 0,2 mg. The preferred daily dosage of malatonin is 36 mg and that of Cyproheptadine is 4 mg per day. The daily intake of Melatonin may vary between 3-200 mg per day and that of Cyproheptadine 4-12 mg per day.
EXAMPLE 10
The procedure of Examples 1 and 2 was followed but the active ingredients were impregnated into the paper of the cigarette.
EXAMPLE 11
Plant material extracted from the Camellia sinensis and rosemary plant were cut, blended and rolled into the form of a string. An inert tasteless binding agent was used to hold the string together. This string was coiled onto a core or spindle for storage and ease of handling. From this coil a length was cut and inserted into a cigarette at the time of manufacture. In use, when the cigarette was smoked, the string burned gradually down the length of the cigarette. The plant material gradually released its active ingredients as the string burned. The string was subjected to an increasing temperature from ambient gradually rising along the length of the string as the burning end of the cigarette proceeded down the length of the cigarette. The progressive increase in temperature allowed the string to release its active components. The components were ingested by the smoker by inhalation.
EXAMPLE 12
Example 11 was repeated but instead of arranging the string linearly along the length of the cigarette it was coiled cylindrically along the cigarette close to the outer paper. In this embodiment the dosage and delivery of the active ingredient was increased as more string containing the active ingredient was incorporated into the cigarette than was incorporated in Example 4.
EXAMPLE 13
Example 11 was repeated but the string was coiled in a smaller diameter coil down the approximate centre line of the cigarette along its length.
EXAMPLE 14
Example 11 was repeated and in this case a tightly compressed coil of string configured in the shape of a watch spring but more tightly wound was incorporated and sandwiched between the filter and tobacco of the requisite.
EXAMPLE 15
Example 11 was repeated several more times and active ingredient in each example was varied by altering the configuration in which the string was incorporated into the requisite. When the string was tightly coiled with the coils being closely spaced to each other, the amount of string in relation to the length of the requisite was increased resulting in a higher concentration of active ingredient per length of requisite. The dosage and delivery rate was altered by either using a loosely wound spaced coil, which resulted in a lower concentration of active ingredient per length of requisite or a tightly wound spaced coil which provided a higher concentration and consequently a higher dosage. To obtain variation in the amount of active ingredient delivered the string was incorporated into the cigarette in various configurations including coiling, zigzagging, straight lengths, wave pattern, rings, individual rings, linked rings, joined looped rings, U-shape, linked U-shape patterns as well as watch spring and Catherine Wheel type patterns.
In one embodiment, the string coil was wound on the outside of the cigarette along its length. In another embodiment, a tightly compressed coil was placed in the filter section of the cigarette. In another embodiment, more than one coil was used and interspersed through the filter of the cigarette. In another embodiment, the coil was placed in the tobacco section of the cigarette. In another embodiment, more than one coil was used and these were placed in the filter section as well as the tobacco section of the cigarette. In another embodiment, more than one coil was used and these were placed in the filter section as well as the tobacco section of the cigarette.
EXAMPLE 16
1000 mg of the analgesic Paracetamol in powder form was encased in a porous cylindrical hollow barrel type cartridge which was then placed longitudinally into a cigarette.
EXAMPLE 17
A porous cartridge was manufactured in which a mix of Epigallocatechin gallate (25 mg) and curcumim (37,5 mg) were placed. This was incorporated in a cigarette directly in front of the filter so that it was sandwiched between the filter and the tobacco of the cigarette.
EXAMPLE 18
Example 10 was repeated and the cartridge was placed in the filter portion of the cigarette.
EXAMPLE 19
A filter for a cigarette was manufactured in which a mixture of Epigallocatechin gallate (25 mg) and curcumin (37,5 mg) from turmeric was impregnated into the filter material. This filter was then used in the manufacture of a smoker's cigarette.
EXAMPLE 20
A filter for a cigarette was manufactured using parts of the Camellia sinensis plant and incorporating these into the filter by rolling and folding strips and portions of the plant into the filter paper.
EXAMPLE 21
Example 20 was repeated four more times with the following changes.
In one embodiment, the plant material was ground and lodged in the filter during the manufacture of the filter.
In another embodiment, the constituent parts of the Camellia sinensis plant were bonded to the filter paper prior to the manufacture of the filter.
In another embodiment, the constituent parts were made to adhere to the filter paper by using pressure to impress these into the paper.
In another embodiment, the constituents of the Camellia sinensis plant were bonded to the filter paper using bonding material which would not adversely affect the taste of the cigarette when this was smoked.
EXAMPLE 22
A filter was constructed using large unrefined sections of the Camellia sinensis plant which were processed and rolled to form a filter.
EXAMPLE 23
Example 22 was repeated but the Camellia sinensis plant was shredded into smaller sections, before being rolled into the shape of a filter.
EXAMPLE 24
Example 22 was repeated using shredded sections of the Camellia sinensis plant.
EXAMPLE 25
A cigarette was made using a blend of shredded Camellia sinensis plant and tobacco.
EXAMPLE 26
Plant material selected from the plant materials of the invention were finely ground and then compacted and tightly packed in a porous cartridge which was then incorporated into a cigarette directly in front of the filter. This cartridge was held in place by being sandwiched between the filter and the tobacco of the requisite.
EXAMPLE 27
Example 26 was repeated several times but the cartridges were placed at various points within the length of the tobacco portion of the cigarette.
EXAMPLE 28
Example 26 was repeated but the cartridge was placed in the filter.
EXAMPLE 29
Example 26 was repeated but more than one cartridge was placed in the tobacco section and in the filter of the cigarette.
EXAMPLE 30
Pulp from grapefruit was desiccated and ground to around 60/100 mesh. Seeds from the grapefruit were dried and ground to around 60/100 mesh. The pulp and seed particles were blended and 50 ml of this blend was mixed into a tobacco mix from which a cigarette was manufactured. This provides protection for humans against mosquito and mosquito related diseases such as malaria.
EXAMPLE 31
In further embodiments, the blend was impregnated into the filter or the cigarette paper or incorporated into a string and used as in Examples 4-8 or incorporated into a porous cartridge and used as in Examples 20-23.
EXAMPLE 32
Pulp from grapefruit was desiccated and ground to around 60/100 mesh. Seeds from the grapefruit were dried and ground to around 60/100 mesh. The pulp and seed particles were blended and 50 mg of this blend was added to 55 mg of artemisia annua and 10 mg of berberine. This mix was mixed into tobacco from which a cigarette was manufactured.
EXAMPLE 33
Examples 11-29 were repeated using the blend of Example 32.
It is an advantage of the invention illustrated that, in the case of a person who is smoking or addicted to smoking, the incorporation of an anti-carcinogenic compound in a cigarette, or in pipe tobacco or the like should serve to reduce or possibly prevent the incidence of cancer which can be caused through smoking. It is also an advantage of the invention illustrated that, where a person has contracted, for example, lung cancer through smoking but nevertheless refuses to stop smoking, the method of the invention can be used to dose the person with a chemotherapeutic agent to treat the cancer. It is also an advantage of the invention illustrated that the invention may be used to provide nutrition, food supplements, drugs, vitamins, remedies or medications to a smoker who may not have cancer.












TABLE 1






Name/Substance/







Compound/Active Ingredient
A
B
C
D
























FORMULA
Methylsulphonylmethane (MSM)






500
mg



Pycnogenol






60
mg



Epigallocatechin gallate (EGCg)






500
mg



D-alpha tocopheryl succinate






100
mg




0.058-87
mg
58
mg
116-1740
mg
1160
mg


FORMULA
Selenium






100
mcg



Pine bark extract






100
mg



Grapeseed extract






100
mg



Epigallocatechin gallate (EGCg)






500
mg



D-alpha tocopheryl succinate






100
mg




4-60
mg
40.0
mg
80-1200.15
mg
800.1
mg


FORMULA
Beta carotene






15
mg



Cryptoxanthin






0.025
mg



Alpha carotene






0.1
mg



Zeaxanthin






0.02
mg



Lutein






10
mg



Lycopene






10
mg



Epigallocatechin gallate (EGCg)






500
mg



Vaccinium myrtillus






60
mg




2.98-44.64
mg
29.7
mg
59.51-892.71
mg
595.14
mg



Gamma-Aminobutyric Acid
50-200
mg
75
mg
1-4
g
1.5
g



Piper methysticum
5-35
mg
15
mg
100-700
mg
300
mg



Standardized Extract (30%-70%



kavalactones)



Scutellaria lateriflora
50-150
mg
50
mg
1-3
g
1
g


FORMULA
Piper methysticum






300
mg



Standardized Extract (30%-70%



kavalactones)



Gamma-Aminobutyric Acid






1.5
mg



Eleutherococcus senticosus






1000
mg




6.51-97.61
mg
65.08
mg
130.1-1952.25
mg
1301.5
mg


FORMULA
Crataegus oxycanthus






1500
mg



Coenzyme Q10






50
mg



Leonurus cardiaca






500
mg



Lycopus virginicus






100
mg



epigallocatechin gallate (EGCg)






500
mg




26.5-172.5
mg
132.5
mg
530-3450
mg
2650
mg



Hypericum perfoliatum
15-45
mg
45
mg
300-900
mg
900
mg



(as standarized extract of 0.3%



Hypericin)



5-Hydroxy-tryptophan
15-30
mg
5
mg
300-600
mg
100
mg



(as seed extract of Griffonia



simplificolia)



Lavandula officinalis
0.1-0.2
ml
0.15
ml
2-4
ml
3
ml



Sterculia acuminata
0.1-0.6
ml
0.15
ml
2-12
ml
3
ml



Panax Ginseng
25-150
mg
50
mg
0.5-3
g
1000
mg



Eleutherococcus senticosus
10-150
mg
50
mg
200-3000
mg
1000
mg



Panax quinquefolius
25-150
mg
50
mg
0.5-3
g
1000
mg



Strychnos ignatii
0.03-0.15
ml
0.05
ml
0.6-3
ml
1
ml



Turnera diffusa
0.1-0.2
ml
0.15
ml
2-4
ml
3
ml



Rhodiola rosea
0.025-0.15
ml
0.075
ml
0.5-3
ml
1.5
ml



Urtica urens
0.1-0.6
ml
0.25
ml
2-12
ml
5
ml



Euphrasia officinalis
0.1-0.6
ml
0.25
ml
2-12
ml
5
ml



Ephedra (Ma Huang 1:4 Ø)
0.125-0.375
ml
0.25
ml
2.5-7.5
ml
5
ml


FORMULA
Ephedra (Ma Huang 1:4 Ø)






500
mg



Euphrasia officinalis






500
mg



Ascorbic acid






500
mg




7.55-112.5
mg
75
mg
150-2250
mg
1500
mg


FORMULA
Achillea millefolium






5
ml



Viscum album






1
ml



Taraxacum officinale






4
ml



Tilia platyphyllos






4
ml



Allium sativum






1
ml




0.075-1.125
ml
0.75
ml
1.5-22.5
ml
15
ml


FORMULA
Achillea millefolium






5
ml



Viscum album






1
ml



Taraxacum officinale






4
ml



Tilia platyphyllos






4
ml



Valeriana officinalis






5
ml



Scutellaria lateriflora






4
ml




0.115-1.725
ml
1.15
ml
2.3-34.5
ml
23
ml



Glucosamine sulphate
12.5-75
mg
75
mg
250-1500
mg
1500
mg



Chondroitin sulphate
5-25
mg
25
mg
100-500
mg
500
mg



Curcumin
12.5-50
mg
12.5
mg
250-1000
mg
250
mg



Salix alba
50-100
mg
12.5
mg
1000-2000
mg
250
mg



Tanacetum parnethium
12.5-75
mg
12.5
mg
250-1500
mg
250
mg



Methylsulphonylmethane (MSM)
5-50
mg
25
mg
100-1000
mg
500
mg



Boswellia serrata
0.5-25
mg
12.5
mg
10-500
mg
250
mg


FORMULA
Glucosamine sulphate






1500
mg



Chondroitin sulphate






500
mg



Curcumin






250
mg



Salix alba






250
mg



Tanacetum parnethium






250
mg



Methylsulphonylmethane (MSM)






500
mg



Equisetum arvensis






50
mg



Copper lysinate






1
mg



Zinc glycinate






10
mg



Manganese sulphate






2
mg



Chelated Selenium






0.1
mg



Epigallocatechin gallate (EGCg)






500
mg




19.07-285.98
mg
190.66
mg
381.3-5719.65
mg
3813.1
mg


FORMULA
Glucosamine sulphate






1500
mg



Chondroitin sulphate






500
mg



Curcumin






250
mg



Boswellia serrata






250
mg



Epigallocatechin gallate (EGCg)






500
mg



Methylsulphonylmethane (MSM)






500
mg



Epigallocatechin (EGC)






200
mg



Pycnogenol






60
mg




18.8-282
mg
188
mg
376-5640
mg
3760
mg



Epigallocatechin gallate (EGCg)
5-125
mg
25
mg
100-2500
mg
500
mg



Epicatechin gallate (ECG)
75-750
mg
150
mg
1.5 g-15
g
3
g



Epigallocatechin (EGC)
75-750
mg
150
mg
1.5 g-15
g
3
g



Gallocatechin gallate (GCG)
75-750
mg
150
mg
1.5 g-15
g
3
g



Gallocatechin (GC)
75-750
mg
150
mg
1.5 g-15
g
3
g



Epicatechin (EC)
75-750
mg
150
mg
1.5 g-15
g
3
g



Catechin (C)
75-750
mg
150
mg
1.5 g-15
g
3
g



Epigallocatechin-3-gallate
5-125
mg
25
mg
100-2500
mg
500
mg



Epicatechin-3-gallate
75-750
mg
150
mg
1.5 g-15
g
3
g


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Epicatechin (EC)






3000
mg



Epicatechin gallate (ECG)






3000
mg



Epigallocatechin (EGC)






3000
mg



d-alpha tocopheryl acetate






100
mg



Ascorbic acid






250
mg




49.25-738.75
mg
492.5
mg
985-14775
mg
9850
mg



Gingko biloba
0.5-12
mg
6
mg
10-240
mg
120
mg



(Standard extract)



Hydrocotyle asiatica
5-30
mg
15
mg
100-600
mg
300
mg



Dimethylaminoethanol Bitartrate
5-20
mg
10
mg
100-400
mg
200
mg



(DMAE)



Rivastigamine
0.075-0.3
mg
0.3
mg
1.5-6
mg
6
mg


FORMULA
Gingko biloba






120
mg



(Standard extract)



Hydrocotyle asiatica






300
mg



Dimethylaminoethanol Bitartrate






200
mg



(DMAE)



Chromium GTF






100
mcg



Thiamine hydrochloride






20
mg



Riboflavin






20
mg



Nicotinamide or Niacinamide






20
mg



Calcium d-Pantothenate






20
mg



Phosphatidyl Choline






50
mg




3.76-56.26
mg
37.5
mg
75.1-1125.15
mg
750.1
mg



Trigonella foenum-graecum
5-100
mg
10
mg
0.1 g-2
g
200
mg



Oplopanax horridum
0.1-0.6
ml
0.2
ml
2-12
ml
4
ml



Phaseolus vulgaris
0.1-0.6
ml
0.2
ml
2-12
ml
4
ml



Vaccinium myrtillus
0.1-0.6
ml
0.2
ml
2-12
ml
6
ml


FORMULA
Trigonella foenum-graecum






3
ml



Oplopanax horridum






4
ml



Phaseolus vulgaris






4
ml



Vaccinium myrtillus






6
ml




0.085-1.275
ml
0.85
ml
1.7-25.5
ml
17
ml



Echinacea purpurea
2.5-150
mg
150
mg
50-3000
mg
3000
mg



Olea europea extract
25-50
mg
50
mg
500-1000
mg
1000
mg



Containing 12% Oleuropein



Astragalus mebricanaceus root
12.5-1500
mg
75
mg
0.25-30
g
1.5
g



Hydrastis canadensis root
12.5-150
mg
150
mg
250-3000
mg
3000
mg



Allium sativa
12.5-1500
mg
250
mg
0.25-30
g
5
g



Calendula officianalis
50-100
mg
75
mg
1-2
g
1.5
g


FORMULA
Echinacea purpurea






3000
mg



Hydrastis canadensis root






3000
mg



Astragalus mebricanaceus root






1500
mg




0.038-0.56
g
0.38
g
0.75-11.25
g
7.5
mg


FORMULA
Sambucus canadensis






2
g



Echinacea purpurea






3000
mg



Hydrastis canadensis root






3000
mg



Allium sativa






5
g




0.065-0.975
g
0.65
g
1.3-19.5
g
13
g


FORMULA
Artemesia annua






750
mg



Berberine






150
mg



Grapefruit seed extract






750
mg



Allium sativa






2500
mg




20.75-311.25
mg
207.5
mg
415-6225
mg
4150
mg



Sambucus nigra
0.1-0.6
ml
0.3
ml
2-12
ml
6
ml



Achillea millefolium
0.1-0.6
ml
0.3
ml
2-12
ml
6
ml



Mentha piperita
0.1-0.6
g
0.25
g
2-12
g
5
g


FORMULA
Triprolidine HCl






3.75
mg



Pseudoephedrine HCl






90
mg



Ascorbic acid






1500
mg



Echinacea purpurea






1.5
g




7.98-119.64
mg
79.76
mg
159.53-2392.88
mg
1595.25
mg


FORMULA
Lecithin




10-5000
mg
500
mg



Nicotinic acid




1-1500
mg
100
mg



Chromium polynicotinate




0.01-0.3
mg
0.2
mg



Allium sativa




10-5000
mg
500
mg



Dioscorea villosa




100-3000
mg
1000
mg



DHEA




10-150
mg
50
mg




21.5-140
mg
107.51
mg
430-2800
mg
2150.2
mg



Althea officinalis
0.1-0.75
ml
0.25
ml
2-15
ml
5
ml



Angelica archangelica
0.1-0.6
ml
0.2
ml
2-12
ml
4
ml



Cephaelis ipecacuanha
0.0125-0.15
ml
0.05
ml
0.25-3
ml
1
ml



Plantago lanceolata
0.1-0.6
ml
0.25
ml
2-12
ml
5
ml



Thymus vulgaris
0.1-0.6
ml
0.2
ml
2-12
ml
4
ml



Salvia officinalis
0.05-0.6
ml
0.2
ml
1-12
ml
4
ml



Commiphora myrrha
0.1-0.75
ml
0.25
ml
2-15
ml
5
ml



Drosera spp.
0.025-0.15
ml
0.05
ml
0.5-3
ml
1
ml


FORMULA
Althea officinalis






5
ml



Thymus vulgaris






4
ml



Salvia officinalis






4
ml




0.065-0.975
ml
0.65
ml
1.3-19.5
ml
13
ml


FORMULA
Plantago lanceolata






5
ml



Commiphora myrrha






5
ml



Drosera spp.






1
ml



Ephedra (Ma Huang 1:4 Ø)






3
ml




0.07-1.05
ml
0.7
ml
1.4-21
ml
14
ml



Humulus lupulus
25-150
mg
100
mg
500-3000
mg
2000
mg



Piper methysticum
5-35
mg
15
mg
100-700
mg
300
mg



Standardized Extract (30%-70%



kavalactones)



Passiflora incarnata
0.025-0.15
ml
0.1
ml
0.5-3
ml
2
ml



Valeriana species
0.1-0.5
ml
0.25
ml
2-10
ml/2
5
ml









hours



Avena sativa
0.05-0.25
ml
0.15
ml
1-5
ml
3
ml


FORMULA
Humulus lupulus






250
mg



Piper methysticum






350
mg



Passiflora incarnata






250
mg



Valeriana species






500
mg



Avena sativa






500
mg



Melatonin






3
mg




9.27-138.98
mg
92.65
mg
185.3-2779.5
mg
1853
mg


FORMULA
Piper methysticum






300
mg



Standardized Extract (30%-70%



kavalactones)



Valerian






1000
mg



gamma-Aminobutyric Acid






1500
mg




14-210
mg
140
mg
280-4200
mg
2800
mg



Turnera diffusa
0.1-0.6
ml
0.2
ml
2-12
ml
4
ml



Serenoa serrulata
0.025-0.15
g
0.075
g
0.5-3
g
1.5
g


FORMULA
Turnera diffusa






4
ml



Serenoa serrulata






5
ml



Avena sativa






3
ml




0.06-0.9
ml
0.6
ml
1.2-18
ml
12
ml



Panax Ginseng
0.5-150
mg
37.5
mg
10-3000
mg
750
mg



Panax Quinefollium
0.5-100
mg
25
mg
10-2000
mg
500
mg



Eleutherococcus senticosus
0.5-200
mg
50
mg
10-4000
mg
1000
mg



Centella asiatica
0.5-50
mg
30
mg
10-1000
mg
600
mg



Paullina guarana
2.5-10
mg
10
mg
50-200
mg
200
mg



Schisandra chinesis
0.5-50
mg
25
mg
10-1000
mg
500
mg



Pfaffia paniculata
0.025-0.225
g
0.15
g
0.5-4.5
g
3
g


FORMULA
Panax Ginseng






750
mg



Centella asiatica






500
mg



Paullina guarana






100
mg



Schisandra chinesis






250
mg



Pfaffia paniculata






500
mg



Epigallocatechin gallate (EGCg)






500
mg




11.75-176.25
mg
117.5
mg
235-3525
mg
2350
mg



Thiamine hydrochloride
0.05-5
mg
5
mg
1-100
mg
100
mg



Riboflavin
0.05-5
mg
5
mg
1-100
mg
100
mg



Nicotinamide or Niacinamide
0.05-5
mg
5
mg
1-100
mg
100
mg



Nicotinic acid or Niacin
0.05-5
mg
5
mg
1-100
mg
100
mg



Pantothenic acid
0.05-5
mg
5
mg
1-100
mg
100
mg



Calcium d-Pantothenate
0.05-5
mg
5
mg
1-100
mg
100
mg



Pyridoxine hydrochloride
0.05-5
mg
5
mg
1-100
mg
100
mg



Cyanocobalamin
0.75-50
mcg
5
mcg
15-1000
mcg
100
mcg



Pangamic acid
0.05-25
mg
15
mg
1-500
mg
300
mg



Biotin
0.05-15
mcg
15
mcg
1-300
mcg
300
mcg



Choline
0.25-25
mg
12.5
mg
5-500
mg
250
mg



Inositol
0.05-750
mg
12.5
mg
1-1500
mg
250
mg



Para-amino benzoic acid
0.05-50
mg
5
mg
1-1000
mg
100
mg



Phosphatidyl Choline
5-200
mg
50
mg
100-4000
mg
1000
mg



Lecithin
5-200
mg
50
mg
100-4000
mg
1000
mg


FORMULA
Retinol palmitate






1.5
mg



Thiamine hydrochloride






10
mg



Riboflavin






5
mg



Nicotinamide or Niacinamide






50
mg



Pantothenic acid






15
mg



Calcium d-Pantothenate






15
mg



Pyridoxine hydrochloride






10
mg



Cyanocobalamin






50
mcg



Folic acid or Folacin






400
mcg



Biotin






100
mcg



Choline






250
mg



Inositol






250
mg



Para-amino benzoic acid






100
mg



Ascorbic acid






1000
mg



Cholecalciferol






5
mcg



d-alpha Tocopheryl acetate






2.5
mcg




8.54-128.03

85.35
mg
170.70-2560.59
mg
1707.06
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Endostatin






300
mg



epicatechin gallate (ECG)






2700
mg




35-227.5
mg
175
mg
700-4550
mg
3500
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Lovastatin






80
mg



epicatechin gallate (ECG)






2700
mg




32.5-213
mg
164
mg
650-4260
mg
3280
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Lodine XL






1000
mg



epicatechin gallate (ECG)






2700
mg




42-273
mg
210
mg
840-5460
mg
4200
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Curcumin






750
mg



epicatechin gallate (ECG)






3000
mg




42.5-275
mg
212.5
mg
850-5500
mg
4250
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Tamoxifen






20
mg



epicatechin gallate (ECG)






3000
mg




42.5-275
mg
212.5
mg
850-5500
mg
4250
mg


FORMULA
Epigallocatechin gallate (EGCg)






500
mg



Selenium






0.2
mg



Lycopene






10
mg



epicatechin gallate (ECG)






3000
mg




35-228
mg
175.51
mg
700-4560
mg
3510.2
mg
















TABLE 2







UNIT DOSAGE














Name/Substance/








Compound/Active Ingredient
A
B
C
D
E




















Acetylsalycilic acid


0.3-4
g
250
mg





Paracetamol


0.5-4
g
0.5
g



Ibuprofen


0.6-1.2
g
200
mg



Indomethacin


50-150
mg
25
mg



Mefenamic acid


500-1500
mg
250
mg



Naproxen


250-750
mg
250
mg



Codeine Phosphate


10-60
mg
5
mg



dl-Phenylalanine


500-1500
mg
500
mg



Salix alba


1000-2000
mg
250
mg



Tanacetum parnethium


250-1500
mg
250
mg



Paracetamol


2000
mg
500
mg



Codeine Phosphate


20
mg
5
mg



Clomipramine HCl


10-75
mg
25
mg



Nortriptyline HCl


25-100
mg
25
mg



Imipramine HCl


75-150
mg
25
mg



Dothepin HCl


25-75
mg
25
mg



Trimipramine HCl


50-100
mg
50
mg



Mianserin HCl


30-90
mg
10
mg



Fluoxetine HCl


20-80
mg
20
mg



Paroxetine HCl


10-50
mg
10
mg



Citalopram hydrobromide


20
mg
20
mg



Sertraline HCl


50-200
mg
50
mg



Verilafaxine HCl


37.5-75
mg
37.5
mg


FORMULA
Hypericum perfoliatum


50-900
mg
300
mg



(as standarized extract of 0.3%



Hypericin)



5-Hydroxy-tryptophan


10-150
mg
50
mg



(as seed extract of Griffonia



simplificolia)








350
mg
35-1050
mg


FORMULA
Hypericum perfoliatum


50-900
mg
300
mg



(as standarized extract of 0.3%



Hypericin)



Eleutherococcus senticosus


200-3000
mg
1000
mg








1300
mg
130-3900
mg


FORMULA
Rhodiola rosea


50-1000
mg
250
mg



5-Hydroxy-tryptophan


100
mg
50
mg



(as seed extract of Griffonia



simplificolia)



Panax Ginseng


0.5-3
g
1000
mg








1300
mg
130-5200
mg



Promethazine HCl


10-100
mg
5
mg



Dexchlorpheneramine mal.


2-8
mg
1
mg



Mepyramine maleate


25-100
mg
5
mg



Prednisone


5-20
mg
1
mg



Betamethasone


0.5-4.5
mg
0.1
mg



















Propanolol HCl10-480 mg 10 mg



















Atenelol HCl
50-100
mg
50
mg


Sotalol Hcl
160-320
mg
80
mg


Captopril
25-150
mg
10
mg


Enalapril maleate
2.5-20
mg
2.5
mg


Losartan
5-20
mg
1
mg


Verapamil HCl
40-360
mg
20
mg


Nifedipine
20-40
mg
5
mg


Glibenclamide
2.5-15
mg
5
mg


Chlorpropramide
100-500
mg
100
mg


Gliclazide
80-320
mg
80
mg


Metformin HCl
0.5 g-3
g
250
mg


Salbutamol
200-1600
mcg
200
mcg


Fenoterol HBr
2.5 mg-15
mg
2.5
mg


Hexoprenaline
0.5 mg-1.5
mg
0.5
mg


Amoxicillin trihydrate
750-1500
mg
250
mg


Ampicillin trihydrate
1000-2000
mg
250
mg


Cloxacillin sodium
500-2000
mg
500
mg


Cephradine
1000-2000
mg
250
mg


Cephalexin monohydrate
1000-4000
mg
250
mg


Cefaclor
750-1500
mg
375
mg


Cefpodoxime
200-400
mg
100
mg


Erythromycin stearate
1000-4000
mg
250
mg


Ibuprofen
0.6-1.2
g
200
mg


Indomethacin
50-150
mg
25
mg


Mefenamic acid
500-1500
mg
250
mg


Naproxen
250-750
mg
250
mg


Acetylsalycillic acid
0.3-4
g
250
mg

## Claims

1. A smoker's requisite, comprising a carrier and a natural product, either alone or in combination with one or more of the following:
a pharmaceutical product; and
a food supplement,
wherein the natural product includes a prenyl flavonoid which is selected from any one, or any combination of the following: prenylchalcones, prenylflavonones, 2-hydroxy-2-methylbut-3-ene and xanthohumol;
the natural product being embodied in the carrier such that, when the requisite is lit and smoked by a smoker, a quantity of the natural product is ingested by the smoker.

2. The smoker's requisite according to claim 1, wherein the carrier is in the form of any one of the following: a package, a cartidge, a filter, a membrane, a pill, a sponge, a matrix, a tablet and a string.

3. The smoker's requisite according to claim 1, wherein the pharmaceutical product is selected from any one, or any combination of the following anti-carcinogenic substances: tofenacin, traodone, viloxazine, interferon, thalidomide, Col-3, tamoxifen, thymidylate synthase inhibitors, COX2 inhibitors, celebrex, rofecoxib (vioxx), imatinib mesylate, gleevec (STI 571) and cyproheptadine.

4. The smoker's requisite according to claim 1, wherein the food supplement is selected from any one, or any combination of the following: a calcium supplement, a tonic and a stimulant.

5. The smoker's requisite according to claim 1, wherein the natural product further comprises a plant substance obtained from camellia sinensis.

6. The smoker's requisite according to claim 1, wherein the natural product further comprises epigallocatechin gallate and the food supplement includes curcumin.

7. The smoker's requisite according to claim 1 wherein, the natural product further comprises a natural anti-carcinogen of the type found in any one, or any combination of the following: catsclaw, olive leaf, olive leaf extract, pau-d'arco, mistletoe, cartilage including shark cartilage, alfalfa, onions, spinach, broccoli, kale, garlic, red bell peppers and beets, fruits, red grapes, white grapes, oranges, strawberries, kiwi fruit, grapefruit, pink grapefruit, tomatoes, apples, camellia sinensis and cocoa.

8. The smoker's requisite according to claim 1, wherein the natural product further comprises a plant substance selected from any one, or any combination of the following: echinacea, ambrosia, marijuana/cannabis, hemp and alfalfa.

9. The smoker's requisite according to claim 1, wherein the natural product further comprises a substance selected from any one, or any combination of the following: tocopherol, alpha-tocopherol, beta-carotene, retinoic acid and ascorbic acid.

10. The smoker's requisite according to claim 1, wherein the prenyl flavonoid is selected from the group consisting of prenylchalcones, prenylflavonones, 2-hydroxy-2-methylbut-3-ene and xanthohumol.

11. The smoker's requisite according to claim 1, wherein the natural product further comprises grapefruit seed extract.

12. A smoker's requisite, comprising:
i) a carrier; and
ii) a natural product selected from the group consisting of prenylchalcones, prenyiflavonones, 2-hydroxy-2-methylbut-3-ene and xanthohumol, and combinations thereof, and
wherein the natural product is present in the carrier so that when the smoker's requisite is lit and smoked by a smoker, a quantity of the natural product is ingested by the smoker.

13. The smoker's requisite according to claim 12, wherein the carrier is in the form selected from the group consisting of a package, a cartridge, a filter, a membrane, a pill, a sponge, a matrix, a tablet and a string.

14. The smoker's requisite according to claim 12, further comprising a pharmaceutical product selected from the group consisting of tofenacin, traodone, viloxazine, interferon, thalidomide, Col-3, tamoxifen, thymidylate synthase inhibitors, COX-2 inhibitors, celebrex, rofecoxib (vioxx), imatinib mesylate, gleevec (STI 571), cyproheptadine and combinations thereof.

15. The smoker's requisite according to claim 12 wherein, the natural product further comprises a natural anti-carcinogen selected from the group consisting of catsclaw, olive leaf, olive leaf extract, pau-d'arco, mistletoe, cartilage including shark cartilage, alfalfa, onions, spinach, broccoli, kale, garlic, red bell peppers, beets, fruits, red grapes, white grapes, oranges, strawberries, kiwi fruit, grapefruit, pink grapefruit, tomatoes, apples, camellia sinensis, cocoa, and combinations thereof.

16. The smoker's requisite according to claim 12, wherein the natural product is selected from the group consisting of tocopherol, aipha-tocopherol, beta-carotene, retinoic acid, ascorbic acid, and combinations thereof.

17. The smoker's requisite according to claim 12, wherein the natural product is selected from the group consisting of prenylchalcones, prenylfiavonones, 2-hydroxy-2-methylbut-3-ene and xanthohumol.